Gabelli & Co Investment Advisers’s Pfizer PFE Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$602K	Hold	25,000	–	–	0.09%	167
2026 Q1	$702K	Hold	25,000	–	–	0.1%	147
2025 Q4	$623K	Hold	25,000	–	–	0.09%	141
2025 Q3	$637K	Hold	25,000	–	–	0.1%	139
2025 Q2	$606K	Sell	25,000 -8,300	-25%	-$194K	0.09%	129
2025 Q1	$844K	Hold	33,300	–	–	0.13%	113
2024 Q4	$883K	Buy	+33,300	New	+$903K	0.15%	107
2024 Q3	–	Sell	-25,000	Closed	-$700K	–	252
2024 Q2	$700K	Buy	25,000 +3,000	+14%	+$82.6K	0.12%	120
2024 Q1	$611K	Buy	+22,000	New	+$610K	0.11%	112

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Gabelli & Co Investment Advisers's PFE Position: Q2 2026 in Review

Gabelli & Co Investment Advisers held its Pfizer (PFE) position steady in Q2 2026 at 25,000 shares worth $602K. The position accounts for 0.09% of the portfolio, ranked #167.

Gabelli & Co Investment Advisers first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. The position peaked at $883K in Q4 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Gabelli & Co Investment Advisers held 25,000 shares of Pfizer worth $602K as of Q2 2026.
Gabelli & Co Investment Advisers left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.09% of Gabelli & Co Investment Advisers's portfolio in Q2 2026, its #167 holding.
Gabelli & Co Investment Advisers first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
Gabelli & Co Investment Advisers's Pfizer position peaked at $883K in Q4 2024.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.